AIM
DRNA

Assured Investment Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Assured Investment Management’s Portfolio DRNA Stock Details DRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-10,364
Closed -$111K – 1424
2018
Q4 		$111K Buy
10,364
+1,486
+17% +$19.5K ﹤0.01% 972
2018
Q3 		$135K Sell
8,878
-18,108
-67% -$264K ﹤0.01% 1006
2018
Q2 		$331K Buy
+26,986
New +$339K 0.01% 925

Other funds holding DRNA

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Assured Investment Management's DRNA Position: Q1 2019 in Review

Assured Investment Management sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q1 2019, closing a stake of 10,364 shares — an estimated $111K sold.

Assured Investment Management first reported a position in DRNA in Q2 2018 and held it in 3 quarters. The position peaked at $331K in Q2 2018. 98 funds tracked by Wall St. Rank hold DRNA as of Q1 2019.

  • Assured Investment Management reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q1 2019 after selling out during the quarter.
  • Assured Investment Management sold 10,364 Dicerna Pharmaceuticals, Inc. shares in Q1 2019, an estimated $111K.
  • Assured Investment Management first reported a position in Dicerna Pharmaceuticals, Inc. in Q2 2018 and held it in 3 quarters.
  • Assured Investment Management's Dicerna Pharmaceuticals, Inc. position peaked at $331K in Q2 2018.
  • 98 funds tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q1 2019.

Based on Assured Investment Management's 13F filing for Q1 2019, filed 16 May 2019.